Hobart Private Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Buy
2,378
+159
+7% +$18.6K 0.05% 118
2026
Q1
$267K Buy
2,219
+295
+15% +$34.1K 0.05% 115
2025
Q4
$203K Buy
+1,924
New +$181K 0.04% 129
2021
Q3
Sell
-4,030
Closed -$313K 117
2021
Q2
$313K Sell
4,030
-1,170
-23% -$87K 0.13% 102
2021
Q1
$383K Sell
5,200
-9,042
-63% -$667K 0.16% 96
2020
Q4
$1.11M Buy
14,242
+788
+6% +$60.3K 0.49% 27
2020
Q3
$1.06M Sell
13,454
-2,214
-14% -$173K 0.55% 25
2020
Q2
$1.16M Buy
15,668
+1,000
+7% +$75.3K 0.65% 30
2020
Q1
$1.08M Buy
14,668
+7,372
+101% +$579K 0.74% 37
2019
Q4
$633K Buy
7,296
+884
+14% +$72.6K 0.39% 61
2019
Q3
$515K Buy
6,412
+152
+2% +$12.2K 0.35% 64
2019
Q2
$501K Buy
6,260
+503
+9% +$38.5K 0.35% 65
2019
Q1
$457K Buy
+5,757
New +$431K 0.35% 74
2018
Q2
Sell
-18,011
Closed -$936K 136
2018
Q1
$936K Buy
18,011
+14
+0.1% +$756 0.82% 45
2017
Q4
$966K Buy
+17,997
New +$998K 0.86% 39

Other funds holding MRK

Hobart Private Capital's MRK Position: Q2 2026 in Review

Hobart Private Capital increased its Merck (MRK) stake by 7.2% in Q2 2026, buying an estimated $18.6K and bringing the position to 2,378 shares worth $306K. The position accounts for 0.05% of the portfolio, ranked #118.

Hobart Private Capital first reported a position in MRK in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.16M in Q2 2020. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hobart Private Capital held 2,378 shares of Merck worth $306K as of Q2 2026.
  • Hobart Private Capital bought 159 Merck shares in Q2 2026, an estimated $18.6K.
  • Merck made up 0.05% of Hobart Private Capital's portfolio in Q2 2026, its #118 holding.
  • Hobart Private Capital first reported a position in Merck in Q4 2017 and has held it in 15 quarters since.
  • Hobart Private Capital's Merck position peaked at $1.16M in Q2 2020.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hobart Private Capital's 13F filing for Q2 2026, filed 6 Jul 2026.